4/A//SEC Filing
PROGENICS PHARMACEUTICALS INC 4/A
Accession 0001447348-16-000060
CIK 0000835887operating
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 5:09 PM ET
Size
5.3 KB
Accession
0001447348-16-000060
Insider Transaction Report
Form 4/AAmended
MADDON PAUL J
Chief Executive Officer/CSO10% Owner
Transactions
- Purchase
Common Stock
2010-12-01$4.90/sh+5,000$24,500→ 909,891 total
Footnotes (3)
- [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $4.85 to $4.98. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This report amends the report filed on December 1, 2010 in order to correct an administrative error in the issuer's records as to the number of shares beneficially owned by the reporting person reported in Column 5 of Table I.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000835887
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 5:09 PM ET
- Size
- 5.3 KB